Global Blood Gas Analyzers Market to Surpass US$ 940 Million by 2026 – Coherent Market Insights

SEATTLE--(BUSINESS WIRE)-- According to Coherent Market Insights, the global blood gas analyzers market was valued at US$ 594.6 million in 2017, and is projected to exhibit a CAGR of 5.5% over the forecast period (2018 – 2026).

Key Trends and Analysis of the Blood Gas Analyzers Market:

Market players are focused on developing cost-effective, easy-to-use blood gas analyzers, which deliver reliable and fast results. For instance, in November 2016, Radiometer introduced ABL9 blood gas analyzer to hospital settings, including point-of-care (PoC), lab and specialized wards, and primary care settings, in Japan, France, Turkey and Germany.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/2603

Moreover, in 2015, Sphere Medical launched arterial blood gas analyzer-- Proxima System in Germany, the Netherlands, and Belgium at ISICEM 2015. The device delivers efficient PoC testing as it offers frequent blood gas measurements. This facilitates effective and timely clinical decisions for proactive critical care.

North America blood gas analyzers market is expected to generate significant revenue share during the forecast period, owing to increasing prevalence of lifestyle-induced diseases and high emergency department visits. According to the Centers for Disease Control and Prevention (CDC) report, in 2017, around 1.7 million emergency department visits with chronic and unspecified bronchitis were recorded in the U.S.

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/blood-gas-analyzers-market-2603

Key Market Takeaways:

• The global blood gas analyzers market is expected to exhibit a CAGR of 5.5% during the forecast period (2018 – 2026). This is attributed to increasing geriatric population that is highly susceptible to various chronic diseases. According to the U.S. Census Bureau, 2015, the number of people aged 65 years and above is expected to increase over 60% during 2015 – 2030 in the U.S.
• Key market players are focused on developing portable blood gas analyzers in order to increase usability and comfort of the analyzers. For instance, in April 2018, Radiometer Limited launched its CE-marked point-of-care tests for creatinine and urea, which is the latest additions to the ABL90 FLEX PLUS blood gas analyzer’s test menu. The versatile ABL90 FLEX PLUS is considered to be the only compact blood gas analyzer in the market to offer such an extensive range of critical care parameters including blood gas, electrolytes, metabolites, and co-oximetry.
• Key players operating in the global blood gas analyzers market include, Abbott Laboratories, Alere, Inc., Bayer AG, Dalko Diagnostics, GE Healthcare, Instrumentation Laboratory, Nova Biomedical, Radiometer, Roche Diagnostics, Siemens Healthcare, and Sphere Medical

Buy this exclusive Business report now @ https://www.coherentmarketinsights.com/insight/buy-now/2603

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190603005323/en/